Health ❯ Healthcare ❯ Medical Research
Immunotherapy Breast Cancer Prostate Cancer mRNA Vaccines Pancreatic Cancer Colorectal Cancer CAR-T Cell Therapy Chemotherapy Glioblastoma Gene Therapy Lung Cancer CAR T Cell Therapy Targeted Therapies Bladder Cancer Clinical Trials Fecal Microbiota Transplantation Antibody-Drug Conjugates Radiation Therapy Cell Therapy Leukemia CAR T-cell Therapy Immune Checkpoint Inhibitors Vaccines Non-Small Cell Lung Cancer Targeted Therapy T-cell Lymphoma Pediatric Oncology HPV Vaccines Diffuse Large B-Cell Lymphoma Tumour-Infiltrating Lymphocytes (TILs) Vaccine Development Ellison Institute of Technology Dendritic Cell Vaccine Non-Hodgkin Lymphoma Head and Neck Cancer Chemotherapy Prediction Radioimmunotherapy Biopsy Techniques Lymphoma Proton Therapy Glioblastoma Treatment Ovarian Cancer Fecal Microbiota Transplants CAR-T Therapy High-Grade Astrocytoma Surgery Research Predictive Analytics Cervical Cancer Nanomedicine Innovative Therapies Philanthropy Genomic Medicine Gene Editing AI in Medicine B-cell Acute Lymphoblastic Leukemia AI in Oncology Radionuclide Therapy Endometrial Cancer Chemotherapy Resistance Triple-Negative Breast Cancer Blood Cancers Melanoma Melanoma Treatment Healthcare Facilities Oropharyngeal Cancer Cancer Vaccines Bacterial Therapy
A peer-reviewed Science study reports mouse tumor clearance using ultra-sensitive receptors that detect very low CD70 levels, prompting plans for a first-in-human safety trial.
